Related Experiment Video

Updated: Apr 18, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.2K

Achilles' heel of triple negative cancer

Alberto Ocaña1, Juan C Montero1, Atanasio Pandiella1

  • 1Instituto de Biología Molecular y Celular del Cáncer. CSIC-Universidad de Salamanca, Spain.

Oncoscience
|January 27, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
06:52

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence

Published on: November 5, 2021

3.8K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.2K
Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
06:52

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence

Published on: November 5, 2021

3.8K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.4K

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K

Articles linked to this work by shared authors, journal, and citation graph.

Guanidine-based drugs in cancer therapy.

Bioorganic chemistry·2026

Tumor-type specific methylation patterns of MTAP in human samples and cell lines.

Clinical epigenetics·2026

Potent anti-tumor activity of CD98hc-targeted antibody-drug conjugates in ovarian cancer.

Signal transduction and targeted therapy·2026

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026

Cooperative molecular interaction networks govern PARP1 inhibitor selectivity and binding affinity.

PLoS computational biology·2026

Guanidine-Based Ligands in Bioinorganic Chemistry: Coordination Modes and Applications in Anticancer Metallodrugs.

Bioinorganic chemistry and applications·2026

Engineering CAR-T cells for solid tumors: Overcoming the microenvironment through integrated design and clinical translation.

Oncoscience·2026

Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report.

Oncoscience·2026

MRI in deciphering the superficial spread of cervical squamous cell carcinoma into the uterine corpus: A case report and literature review.

Oncoscience·2026

Targeting leucine-rich alpha-2-glycoprotein-1 (LRG1) and the LRG1-cytochrome c-Apaf-1 axis in cancer therapy.

Oncoscience·2026

The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma.

Oncoscience·2026

Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression.

Oncoscience·2026

Cell biology of cancer dormancy.

Journal of cell science·2026

Research progress and trends in clinical trials for older people with colorectal cancer from 2005 to 2025: a bibliometric analysis.

Chinese clinical oncology·2026

Gastric cancer in the Era of neural regulation.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu·2026

A programmed cell death learning signature predicts immunotherapy response and identifies AP1S1 as a regulator of immune exclusion in breast cancer.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu·2026

Overcoming barriers to bladder preservation: Emerging intravesical therapies for high-risk non-muscle-invasive bladder cancer.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu·2026

Obesity-driven adipokine signaling in breast cancer: mechanistic insights, therapeutic challenges, and opportunities for precision oncology.

Journal of pathology and translational medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us